Prim (LTS:0FP0) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0FP0 Prim SA LTS:0FP0
78 GF Score
Price €13.25
GF Value €8.05
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Prim FFO per Share?

FFO per Share only applies to REITs.

LTS:0FP0
78GF Score
Prim SA LTS:0FP0
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Prim (LTS:0FP0) Overvalued in 2026?

Based on GuruFocus' analysis, Prim stock appears to be overvalued. The current stock price of €13.25 is trading 64.6% above its estimated GF Value™ of €8.05. GuruFocus considers Prim to be Significantly Overvalued.

Key valuation signals for LTS:0FP0:

  • FFO per Share:
  • GF Value™: €8.05 vs. price of €13.25 (64.6% above fair value)
  • GF Score™: 78/100 with 5 warning signs

No single metric tells the full story. See the LTS:0FP0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Prim Business Description

Other Exchanges PRM:Spain5P1:Germany
Address Calle F, numero 15, Poligono Industrial 1, Mostoles, Madrid, ESP, 28938
Prim SA is engaged in the provision of hospital supplies. The company is in a hospital and orthopedic supplies and materials for physiotherapy, thalassotherapy, thermal therapy, rehabilitation, geriatrics, as well as daily living aids. Prim work across a division of healthcare units such as Operating Theatres; Pain Management Centres; Plastic Surgery; Endosurgery and Cardiovascular.
78GF Score

Get the complete analysis for LTS:0FP0

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€13.25
Price
€8.05
GF Value